Pure Global AI
ANVISA registration 10269360504Valid until Jul 27, 2036

PROSTATE-SPECIFIC ANTIGEN (PSA)

ANVISA Registration Number: 10269360504QUIBASA - QUIMICA BASICA LTDAQUIBASA QUÍMICA BÁSICA LTDARisk Class III
Device names
Technical name
PROSTATE-SPECIFIC ANTIGEN (PSA)
PT: ANTÍGENO PROSTÁTICO ESPECÍFICO (PSA)
Commercial name
BIOCLIN POCT FIA PSA TOTAL
Risk class
Class III
Registration details
Registration Number
10269360504
Process Number
25351084871202666
CNPJ
19400787000107
Company information
Manufacturing Country
Brazil
PT: BRASIL
Dates and status
Publication Date
Jul 27, 2026
Validity
27/07/2036
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for PROSTATE-SPECIFIC ANTIGEN (PSA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10269360504 and manufactured by QUIBASA QUÍMICA BÁSICA LTDA. The registration is held by QUIBASA - QUIMICA BASICA LTDA with validity until Jul 27, 2036.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.